The community pharmacist is uniquely situated to provide sustained continuity for patients with or at risk for heart disease. Pharmacists must continue their own education regarding coronary heart disease, so that they can educate and support patients between physician appointments, identify patients needing medical attention, and serve as a community resource for promoting a healthy lifestyle.
Smith SC, Allen J, Blair SN, et al.AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation. 2006;113;2363-2372.
2.
ACPE Accreditation Manual. Version 9.1. February 2004. Available at: www.acpeaccredt.org.
3.
Bluml BM, McKenney JM, Cziraky MJ.Pharmaceutical care services and results in project ImPACT: hyperlipidemia. J Am Pharm Assoc.2000;40: 157-165.
4.
Best Practices for Hospital and Health-System Pharmacies: Position and Practice Standards of ASHP 2005-2006. Bethesda, Md: American Society of Health-System Pharmacists; 2005.
5.
Centers for Disease Control and Prevention. Coverage for tobacco use cessation treatments. Available at: www.cdc.gov/tobacco/educational_materials/cessation/ReimbursementBrochureFull.pdf.
6.
Calis KA, Hutchison LC, Elliott ME, et al.Healthy People 2010: challenges, opportunities, and a call to action for America's pharmacists. ACCP White Paper. Pharmacotherapy. 2004;24: 1241-1294.
